Source: PR Newswire

Press Release: Laronde : Laronde to Present at the RNA Leaders Europe Congress

Avak Kahvejian, Co-Founder and Chief Scientific Officer, to Present on "Programmable Medicines 2.0 with Endless RNA" SOMERVILLE, Mass., March 14, 2023 /PRNewswire/ -- Laronde, the company pioneering Endless RNA (eRNA) - a novel, engineered form of RNA that can be programmed to express...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
John Mendlein's photo - Interim-CEO of Laronde

Interim-CEO

John Mendlein

CEO Approval Rating

90/100

Read more